Literature DB >> 12897779

Cyclophilin A modulates the sensitivity of HIV-1 to host restriction factors.

Greg J Towers1, Theodora Hatziioannou, Simone Cowan, Stephen P Goff, Jeremy Luban, Paul D Bieniasz.   

Abstract

Many mammalian species express restriction factors that confer host resistance to retroviral infection. Here we show that HIV-1 sensitivity to restriction factors is modulated by cyclophilin A (CypA), a host cell protein that binds the HIV-1 capsid protein (CA). In certain nonhuman primate cells, the CA-CypA interaction is essential for restriction: HIV-1 infectivity is increased >100-fold by cyclosporin A (CsA), a competitive inhibitor of the interaction, or by an HIV-1 CA mutation that disrupts CypA binding. Conversely, disruption of CA-CypA interaction in human cells reveals that CypA protects HIV-1 from the Ref-1 restriction factor. These findings suggest that HIV-1 has co-opted a host cell protein to counteract restriction factors expressed by human cells and that this adaptation can confer sensitivity to restriction in unnatural hosts. Manipulation of HIV-1 CA recognition by restriction factors promises to advance animal models and new therapeutic strategies for HIV-1 and AIDS.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12897779     DOI: 10.1038/nm910

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


  211 in total

1.  In defense of the cell: TRIM5alpha interception of mammalian retroviruses.

Authors:  Kyeongeun Lee; Vineet N KewalRamani
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-13       Impact factor: 11.205

2.  Retroviral capsid determinants of Fv1 NB and NR tropism.

Authors:  Anthony Stevens; Michael Bock; Scott Ellis; Paul LeTissier; Kate N Bishop; Melvyn W Yap; Willie Taylor; Jonathan P Stoye
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

3.  A Trim5-cyclophilin A fusion protein found in owl monkey kidney cells can restrict HIV-1.

Authors:  Sébastien Nisole; Clare Lynch; Jonathan P Stoye; Melvyn W Yap
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-23       Impact factor: 11.205

4.  HIV-1 capsid-targeting domain of cleavage and polyadenylation specificity factor 6.

Authors:  Kyeongeun Lee; Alok Mulky; Wendy Yuen; Thomas D Martin; Nicholas R Meyerson; Laura Choi; Hyun Yu; Sara L Sawyer; Vineet N Kewalramani
Journal:  J Virol       Date:  2012-02-01       Impact factor: 5.103

5.  Non-cleavage site gag mutations in amprenavir-resistant human immunodeficiency virus type 1 (HIV-1) predispose HIV-1 to rapid acquisition of amprenavir resistance but delay development of resistance to other protease inhibitors.

Authors:  Manabu Aoki; David J Venzon; Yasuhiro Koh; Hiromi Aoki-Ogata; Toshikazu Miyakawa; Kazuhisa Yoshimura; Kenji Maeda; Hiroaki Mitsuya
Journal:  J Virol       Date:  2009-01-28       Impact factor: 5.103

Review 6.  Molecular evolution of the antiretroviral TRIM5 gene.

Authors:  Welkin E Johnson; Sara L Sawyer
Journal:  Immunogenetics       Date:  2009-02-24       Impact factor: 2.846

7.  Pseudoproteoglycan (pseudoPG) probes that simulate PG macromolecular structure for screening and isolation of PG-binding proteins.

Authors:  Keiko Nakagawa; Kosuke Nakamura; Yuji Haishima; Makiko Yamagami; Kana Saito; Hiromi Sakagami; Haruko Ogawa
Journal:  Glycoconj J       Date:  2009-11       Impact factor: 2.916

8.  Analysis of human cell heterokaryons demonstrates that target cell restriction of cyclosporine-resistant human immunodeficiency virus type 1 mutants is genetically dominant.

Authors:  Chisu Song; Christopher Aiken
Journal:  J Virol       Date:  2007-08-22       Impact factor: 5.103

9.  Cyclophilin A-dependent restriction to capsid N121K mutant human immunodeficiency virus type 1 in a broad range of cell lines.

Authors:  Taichiro Takemura; Miyako Kawamata; Miho Urabe; Tsutomu Murakami
Journal:  J Virol       Date:  2013-01-16       Impact factor: 5.103

10.  Host factors that affect Ty3 retrotransposition in Saccharomyces cerevisiae.

Authors:  Michael Aye; Becky Irwin; Nadejda Beliakova-Bethell; Eric Chen; Jennifer Garrus; Suzanne Sandmeyer
Journal:  Genetics       Date:  2004-11       Impact factor: 4.562

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.